WEKO3
アイテム
{"_buckets": {"deposit": "38ea0ce6-9998-4f99-ad7d-d579d48778d7"}, "_deposit": {"created_by": 28, "id": "1868", "owners": [28], "pid": {"revision_id": 0, "type": "depid", "value": "1868"}, "status": "published"}, "_oai": {"id": "oai:oist.repo.nii.ac.jp:00001868", "sets": ["67"]}, "author_link": ["11286", "11292", "11284", "11283", "11287", "11290", "11289", "11285", "11291", "11293", "11281", "11288", "11282"], "item_10001_biblio_info_7": {"attribute_name": "Bibliographic Information", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2019-11-18", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "11", "bibliographicPageStart": "1812", "bibliographicVolumeNumber": "11", "bibliographic_titles": [{}, {"bibliographic_title": "Cancers", "bibliographic_titleLang": "en"}]}]}, "item_10001_creator_3": {"attribute_name": "Author", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Oh, Ju Yeon"}], "nameIdentifiers": [{"nameIdentifier": "11281", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kim, Eun Ho"}], "nameIdentifiers": [{"nameIdentifier": "11282", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Lee, Yeon-Joo"}], "nameIdentifiers": [{"nameIdentifier": "11283", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sai, Sei"}], "nameIdentifiers": [{"nameIdentifier": "11284", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Lim, Sun Ha"}], "nameIdentifiers": [{"nameIdentifier": "11285", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Park, Jang Woo"}], "nameIdentifiers": [{"nameIdentifier": "11286", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Chung, Hye Kyung"}], "nameIdentifiers": [{"nameIdentifier": "11287", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kim, Joon"}], "nameIdentifiers": [{"nameIdentifier": "11288", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Vares, Guillaume"}], "nameIdentifiers": [{"nameIdentifier": "11289", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Takahashi, Akihisa"}], "nameIdentifiers": [{"nameIdentifier": "11290", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Jeong, Youn Kyoung"}], "nameIdentifiers": [{"nameIdentifier": "11291", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kim, Mi-Sook"}], "nameIdentifiers": [{"nameIdentifier": "11292", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kong, Chang-Bae"}], "nameIdentifiers": [{"nameIdentifier": "11293", "nameIdentifierScheme": "WEKO"}]}]}, "item_10001_description_5": {"attribute_name": "Abstract", "attribute_value_mlt": [{"subitem_description": "Osteosarcoma (OS) originates from osteoid bone tissues and is prone to metastasis, resulting in a high mortality rate. Although several treatments are available for OS, an effective cure does not exist for most patients with advanced OS. Zoledronic acid (ZOL) is a third-generation bisphosphonate that inhibits osteoclast-mediated bone resorption and has shown efficacy in treating bone metastases in patients with various types of solid tumors. Here, we sought to clarify the mechanisms through which ZOL inhibits OS cell proliferation. ZOL treatment inhibited OS cell proliferation, viability, and colony formation. Autophagy inhibition by RNA interference against Beclin-1 or ATG5 inhibited ZOL-induced OS cell death. ZOL induced autophagy by repressing the protein kinase B/mammalian target of rapamycin/p70S6 kinase pathway and extracellular signal-regulated kinase signaling-dependent autophagy in OS cell lines and patient-derived OS cells. Microarrays of miRNA showed that ZOL increased the levels of miR-212-3p, which is known to play an important role in autophagy, in OS in vitro and in vivo systems. Collectively, our data provided mechanistic insight into how increased miR-212-3p through ZOL treatment induces autophagy synergistically in OS cells, providing a preclinical rationale for conducting a broad-scale clinical evaluation of ZOL + miR-212-3p in treating OS.", "subitem_description_type": "Other"}]}, "item_10001_publisher_8": {"attribute_name": "Publisher", "attribute_value_mlt": [{"subitem_publisher": "MDPI"}]}, "item_10001_relation_13": {"attribute_name": "PubMedNo.", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "info:pmid/31752184", "subitem_relation_type_select": "PMID"}}]}, "item_10001_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "info:doi/10.3390/cancers11111812", "subitem_relation_type_select": "DOI"}}]}, "item_10001_relation_17": {"attribute_name": "Related site", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "First published Article"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://www.mdpi.com/2072-6694/11/11/1812", "subitem_relation_type_select": "URI"}}, {"subitem_relation_name": [{"subitem_relation_name_text": "Correction"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://www.mdpi.com/2072-6694/12/6/1359", "subitem_relation_type_select": "URI"}}]}, "item_10001_rights_15": {"attribute_name": "Rights", "attribute_value_mlt": [{"subitem_rights": "© 2019 The Author(s)."}]}, "item_10001_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "2072-6694", "subitem_source_identifier_type": "ISSN"}]}, "item_10001_version_type_20": {"attribute_name": "Author\u0027s flag", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2021-01-06"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "cancers-11-01812-v2.pdf", "filesize": [{"value": "3.8 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensefree": "Creative Commons Attribution 4.0 International (https://creativecommons.org/licenses/by/4.0/)", "licensetype": "license_free", "mimetype": "application/pdf", "size": 3800000.0, "url": {"label": "cancers-11-01812-v2", "url": "https://oist.repo.nii.ac.jp/record/1868/files/cancers-11-01812-v2.pdf"}, "version_id": "af9005b8-13ea-4e55-b3b9-08050d4598e7"}, {"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2021-01-06"}], "displaytype": "detail", "download_preview_message": "", "file_order": 1, "filename": "Oh-2020-Correction_ Oh, J.Y., et al. Synergist.pdf", "filesize": [{"value": "5.8 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensefree": "Creative Commons Attribution 4.0 International (https://creativecommons.org/licenses/by/4.0/)", "licensetype": "license_free", "mimetype": "application/pdf", "size": 5800000.0, "url": {"label": "Oh-2020-Correction_ Oh, J.Y., et al. Synergist", "url": "https://oist.repo.nii.ac.jp/record/1868/files/Oh-2020-Correction_ Oh, J.Y., et al. Synergist.pdf"}, "version_id": "e31d1627-8c5a-4981-a619-b163c2b37bc0"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "zoledronic acid", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "osteosarcoma", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "autophagy", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "miR-212", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Synergistic Autophagy Effect of miR-212-3p in Zoledronic Acid-Treated In Vitro and Orthotopic In Vivo Models and in Patient-Derived Osteosarcoma Cells", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Synergistic Autophagy Effect of miR-212-3p in Zoledronic Acid-Treated In Vitro and Orthotopic In Vivo Models and in Patient-Derived Osteosarcoma Cells", "subitem_title_language": "en"}]}, "item_type_id": "10001", "owner": "28", "path": ["67"], "permalink_uri": "https://oist.repo.nii.ac.jp/records/1868", "pubdate": {"attribute_name": "公開日", "attribute_value": "2021-01-06"}, "publish_date": "2021-01-06", "publish_status": "0", "recid": "1868", "relation": {}, "relation_version_is_last": true, "title": ["Synergistic Autophagy Effect of miR-212-3p in Zoledronic Acid-Treated In Vitro and Orthotopic In Vivo Models and in Patient-Derived Osteosarcoma Cells"], "weko_shared_id": 28}
Synergistic Autophagy Effect of miR-212-3p in Zoledronic Acid-Treated In Vitro and Orthotopic In Vivo Models and in Patient-Derived Osteosarcoma Cells
https://oist.repo.nii.ac.jp/records/1868
https://oist.repo.nii.ac.jp/records/1868861b6b21-7a07-4901-a66d-19a06e1330b6
名前 / ファイル | ライセンス | アクション |
---|---|---|
cancers-11-01812-v2 (3.8 MB)
|
Creative Commons Attribution 4.0 International (https://creativecommons.org/licenses/by/4.0/)
|
|
Oh-2020-Correction_ Oh, J.Y., et al. Synergist (5.8 MB)
|
Creative Commons Attribution 4.0 International (https://creativecommons.org/licenses/by/4.0/)
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2021-01-06 | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | Synergistic Autophagy Effect of miR-212-3p in Zoledronic Acid-Treated In Vitro and Orthotopic In Vivo Models and in Patient-Derived Osteosarcoma Cells | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | zoledronic acid | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | osteosarcoma | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | autophagy | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | miR-212 | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者(英) |
Oh, Ju Yeon
× Oh, Ju Yeon× Kim, Eun Ho× Lee, Yeon-Joo× Sai, Sei× Lim, Sun Ha× Park, Jang Woo× Chung, Hye Kyung× Kim, Joon× Vares, Guillaume× Takahashi, Akihisa× Jeong, Youn Kyoung× Kim, Mi-Sook× Kong, Chang-Bae |
|||||
書誌情報 |
en : Cancers 巻 11, 号 11, p. 1812, 発行日 2019-11-18 |
|||||
抄録 | ||||||
内容記述タイプ | Other | |||||
内容記述 | Osteosarcoma (OS) originates from osteoid bone tissues and is prone to metastasis, resulting in a high mortality rate. Although several treatments are available for OS, an effective cure does not exist for most patients with advanced OS. Zoledronic acid (ZOL) is a third-generation bisphosphonate that inhibits osteoclast-mediated bone resorption and has shown efficacy in treating bone metastases in patients with various types of solid tumors. Here, we sought to clarify the mechanisms through which ZOL inhibits OS cell proliferation. ZOL treatment inhibited OS cell proliferation, viability, and colony formation. Autophagy inhibition by RNA interference against Beclin-1 or ATG5 inhibited ZOL-induced OS cell death. ZOL induced autophagy by repressing the protein kinase B/mammalian target of rapamycin/p70S6 kinase pathway and extracellular signal-regulated kinase signaling-dependent autophagy in OS cell lines and patient-derived OS cells. Microarrays of miRNA showed that ZOL increased the levels of miR-212-3p, which is known to play an important role in autophagy, in OS in vitro and in vivo systems. Collectively, our data provided mechanistic insight into how increased miR-212-3p through ZOL treatment induces autophagy synergistically in OS cells, providing a preclinical rationale for conducting a broad-scale clinical evaluation of ZOL + miR-212-3p in treating OS. | |||||
出版者 | ||||||
出版者 | MDPI | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 2072-6694 | |||||
PubMed番号 | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | PMID | |||||
関連識別子 | info:pmid/31752184 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | info:doi/10.3390/cancers11111812 | |||||
権利 | ||||||
権利情報 | © 2019 The Author(s). | |||||
関連サイト | ||||||
識別子タイプ | URI | |||||
関連識別子 | https://www.mdpi.com/2072-6694/11/11/1812 | |||||
関連名称 | First published Article | |||||
関連サイト | ||||||
識別子タイプ | URI | |||||
関連識別子 | https://www.mdpi.com/2072-6694/12/6/1359 | |||||
関連名称 | Correction | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 |